BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 837372)

  • 21. Induction of chemotaxis in mouse peritoneal macrophages by phorbol ester tumor promoters.
    Laskin DL; Laskin JD; Weinstein IB; Carchman RA
    Cancer Res; 1981 May; 41(5):1923-8. PubMed ID: 7214360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Partial characterization of a novel chemotactic factor produced by macrophages.
    Gómez-Flores R; Tamez-Guerra R
    Rev Latinoam Microbiol; 1992; 34(1):67-70. PubMed ID: 1345307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.
    Nakajima H; Fujiwara H; Takai Y; Izumi Y; Sano S; Tsuchida T; Hamaoka T
    J Immunol; 1985 Sep; 135(3):2199-205. PubMed ID: 3894520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective chemotaxis of Ia antigen-positive macrophages by macrophage chemotactic lymphokine produced by concanavalin A stimulation.
    Miura K; Honda M; Yoshimura T; Hayashi H
    Immunology; 1984 Aug; 52(4):641-7. PubMed ID: 6589206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemotaxis of rat lymphocytes.
    Ward PA; Unanue ER; Goralnick SJ; Schreiner GF
    J Immunol; 1977 Aug; 119(2):416-21. PubMed ID: 142111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of Ia antigen expression in macrophages derived from bone marrow cells cultured in granulocyte-macrophage colony-stimulating factor or macrophage colony-stimulating factor.
    Falk LA; Wahl LM; Vogel SN
    J Immunol; 1988 Apr; 140(8):2652-60. PubMed ID: 3128601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody-mediated suppression of grafted lymphoma. III. Evaluation of the role of thymic function, non-thymus-derived lymphocytes, macrophages, platelets, and polymorphonuclear leukocytes in syngeneic and allogeneic hosts.
    Shin HS; Hayden M; Langley S; Kaliss N; Smith MR
    J Immunol; 1975 Apr; 114(4):1255-63. PubMed ID: 1078832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Macrophage depletion test in guinea pigs].
    Zschiesche W
    Allerg Immunol (Leipz); 1976; 22(1):105-8. PubMed ID: 135493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macrophage content of murine sarcomas and carcinomas: associations with tumor growth parameters and tumor radiocurability.
    Milas L; Wike J; Hunter N; Volpe J; Basic I
    Cancer Res; 1987 Feb; 47(4):1069-75. PubMed ID: 3802091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunophenotypical changes of neoplastic cells and tumor-associated macrophages in a rat dendritic cell sarcoma-derived transplantable tumor line (KB-D8).
    Kawashima M; Ide M; Nakanishi M; Kuwamura M; Kumagai D; Yamate J
    Virchows Arch; 2003 Feb; 442(2):141-50. PubMed ID: 12596065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mouse mononuclear cell chemotaxis. I. Differential response of monocytes and macrophages.
    Boumsell L; Meltzer MS
    J Immunol; 1975 Dec; 115(6):1746-8. PubMed ID: 1184970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cultured tumor cells produce chemotactic factors specific for endothelial cells: a possible mechanism for tumor-induced angiogenesis.
    Seppä ST; Seppä HE; Liotta LA; Glaser BM; Martin GR; Schiffmann E
    Invasion Metastasis; 1983; 3(3):139-50. PubMed ID: 6203869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thymocyte and macrophage interactions: separation of murine thymocyte subsets and enrichment of syngeneic cell-responding thymocytes by adsorption to macrophage monolayers.
    Wu S; Thomas DW
    J Immunol; 1983 Nov; 131(5):2110-6. PubMed ID: 6226732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2.
    Alleva DG; Burger CJ; Elgert KD
    J Immunol; 1994 Aug; 153(4):1674-86. PubMed ID: 8046239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antitumor Effector mechanism of plant alkaloid preparation, cepharanthin, by intratumoral administration].
    Ebina T; Murata K
    Gan To Kagaku Ryoho; 1991 Aug; 18(11):1812-6. PubMed ID: 1877822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of plasmacytoma cells on the production of granulocyte-macrophage colony-stimulating activity (GM-CSA) in the spleen of tumor-bearing mice.
    Merchav S; Apte RN; Tatarsky I; Ber R
    Exp Hematol; 1987 Oct; 15(9):995-1000. PubMed ID: 3498643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of a macrophage chemokinetic factor in tumor cell culture media.
    Lane RD; Kaplan AM; Snodgrass MJ; Szakal AK
    J Reticuloendothel Soc; 1982 Feb; 31(2):171-84. PubMed ID: 7062320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemotactic response of splenic mononuclear cells to angiotensin II in murine schistosomiasis.
    Weinstock JV; Kassab J
    J Immunol; 1986 Sep; 137(6):2020-4. PubMed ID: 3091696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of neoplasms on inflammation: depression of macrophage accumulation after tumor implantation.
    Snyderman R; Pike MC; Blaylock BL; Weinstein P
    J Immunol; 1976 Mar; 116(3):585-9. PubMed ID: 176265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defective tumoricidal capacity of macrophages from P/J mice: characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli.
    Boraschi D; Meltzer MS
    J Immunol; 1980 Aug; 125(2):771-6. PubMed ID: 6993562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.